morbidity and mortality represents a growing public health priority. Building on the theme of
aging and immunosenescence, we review mechanisms of human immunosenescence and
the immune response to currently licensed vaccines. We discuss the difficulties in identifying
the risk factors that, in addition to aging, cause immunosenescence and address the relative
paucity of vaccine studies in the elderly. We conclude that vaccine responses are blunted in …